AbstractPurpose The inclusion of patient-reported outcome (PRO) questionnaires in prognostic factor analyses in...
Posted by : Pr. Franck BONNETAIN
Journal name : Quality of Life Research
AbstractPurpose The inclusion of patient-reported outcome (PRO) questionnaires in prognostic factor analyses in...
Posted by : Pr. Franck BONNETAIN
Journal name : Quality of Life Research
ABSTRACTIntroductionWhile there is mounting evidence of the independent prognostic value of patient-reported outcomes...
Posted by : Pr. Franck BONNETAIN
Journal name : BMJ Open
AbstractBACKGROUND:The incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades....
Posted by : Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Lancet Oncol
AbstractBACKGROUND:At time of diagnosis, less than 10% of patients with pancreatic adenocarcinomas (PDAC) are considered...
Posted by : Dr. Dewi VERNEREY
Journal name : BMC Cancer
ABSTRACTBackground: Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side...
Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : The Breast
Letter to editor.LINK
Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Journal name : European Journal of Cancer
ABSTRACTBackgroundSunitinib is a tyrosine kinase inhibitor approved in the first-line metastatic renal cell carcinoma...
Posted by : , Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Trials
BACKGROUND:Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard...
Posted by : Dr. Dewi VERNEREY
Journal name : New England Journal of Medicine
ABSTRACTPurpose Reduction of adjuvant treatment duration may decrease toxicities without loss of efficacy in stage III...
Posted by : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Journal name : Journal of Clinical Oncology
BACKGROUND:RAS mutations are currently sought for in tumor samples, which takes a median of almost 3 weeks in western...
Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Journal name : Ann Oncol
BACKGROUND:Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and...
Posted by : Dr. Dewi VERNEREY
Journal name : Exp Hematol Oncol
ABSTRACTBackground and objective: Health-related quality of life (HRQoL) has become one relevant and available...
Posted by : Pr. Franck BONNETAIN
Journal name : Computer Methods and Programs in Biomedicine
With advances in breast cancer (BC) gene panel testing, risk counseling has become increasingly complex, potentially...
Posted by : Pr. Franck BONNETAIN
Journal name : International Journal of Environmental Research and Public Health
PurposeThe aim of this study was to determine the prevalence of adherence to adjuvant hormonal therapy (AHT) and to...
Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : Breast Cancer Research and Treatment
BackgroundPatients treated with chemotherapy for microsatellite unstable (MSI) and/or mismatch repair deficient (dMMR)...
Posted by : Dr. Dewi VERNEREY
Journal name : Eur J Cancer